Latest Breaking News On - Arno capital - Page 1 : comparemela.com
Caresyntax Raises Additional $30M; Brings Series C To $130M
finsmes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finsmes.com Daily Mail and Mail on Sunday newspapers.
Q2 wraps up with more than $6 2 billion in digital health investments
mobihealthnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mobihealthnews.com Daily Mail and Mail on Sunday newspapers.
Caresyntax Raises $100 Million to Make Surgery Smarter and Safer
Investment will strengthen technology and expand company s reach
News provided by
Share this article
Share this article
BOSTON, April 28, 2021 /PRNewswire/ Caresyntax, the leading enterprise-level digital surgery platform delivering actionable insights to make surgery smarter and safer, today announced that it has closed a $100 million Series C funding round led by PFM Health Sciences LP, and included participation from Optum Ventures, Intel Capital, Lauxera Capital Partners, Vesalius Biocapital III, Arno Capital, Rezayat Investments, as well as current investors IPF Partners, the Relyens Group, and Surgical.AI. The investment follows a year in which the company saw 250% growth in new contract value, supported more than 30,000 surgeons, and improved care for more than two million patients.
Photo by IronHeart/Getty Images
Digital pharmacy Capsule has completed another massive funding round, this time worth $300 million, according to
The added investments value the New York-based startup at more than $1 billion, Capsule CEO Eric Kinariwala said in an interview. This, plus Capsule’s past raises, brings its total funding to date to $570 million.
The funds will go towards market expansion and technology updates, Bloomberg reported.
Caresyntax, a digital surgery platform, has closed a $100 million Series C funding round led by PFM Health Sciences LP.
New investors Optum Ventures, Intel Capital, Lauxera Capital Partners, Vesalius Biocapital III, Arno Capital, Rezayat Investments, as well as existing investors IPF Partners, the Relyens Group and Surgical.AI also participated in the raise.
vimarsana © 2020. All Rights Reserved.